Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users
- 30 May 2017
- journal article
- review article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 24 (12) , 1082-1088
Abstract
Summary: A rare outcome following exposure to hepatitis C virus (HCV) is a lack of observable infection as clinically measured by HCV RNA‐ or HCV‐recognizing antibodies. The population who exhibit this trait is termed exposed uninfected (EU). Increasing evidence has refined characterization of these individuals, distinct from those who become infected but spontaneously clear HCV. Study of the EU population is highly pertinent for the discovery of antiviral mechanisms of resistance that can reveal antiviral therapeutic strategies. This review provides an overview of similarities and differences of the EU population relative to spontaneous resolvers and the majority whom develop chronic HCV infection, and focusses on possible mechanisms of resistance including innate and adaptive immunity, genetics and lipid interactions.Keywords
This publication has 60 references indexed in Scilit:
- Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell ExhaustionThe Journal of Infectious Diseases, 2012
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV InfectionGastroenterology, 2011
- Loss of Virus-specific T-Cell Responses in HCV Exposed Uninfected Injection Drug Users With Drug RehabilitationThe Journal of Infectious Diseases, 2011
- Increased Natural Killer Cell Cytotoxicity and NKp30 Expression Protects Against Hepatitis C Virus Infection in High-Risk Individuals and Inhibits Replication In VitroHepatology, 2010
- Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent ReinfectionGastroenterology, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCVThe Journal of Infectious Diseases, 2008
- Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteinsJournal of General Virology, 2006
- Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate themEpidemiology and Infection, 2006